Emergent BioSolutions (EBS) FCF Margin (2011 - 2026)
Emergent BioSolutions (EBS) posted FCF Margin of 23.05% for Q2 2026, down 50.41 percentage points from 73.46% a year earlier but up 46.24 percentage points from the prior quarter.
Emergent BioSolutions (EBS) FCF Margin (2011 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, FCF Margin at Emergent BioSolutions was 11.15%, down 7.05 percentage points year-over-year; for FY2025, it came in at 21.11%, up 17.68 percentage points from FY2024.
- Annual FCF Margin has increased for three consecutive years, though with a five-year change of -3.94 percentage points (FY2020 to FY2025).
- In prior years, Emergent BioSolutions' FCF Margin was 3.43% in FY2024 (+28.01 pp), -24.58% in FY2023 (+0.28 pp), -24.86% in FY2022 (-30.28 pp) and 5.42% in FY2021 (-19.62 pp).
- Quarterly FCF Margin has run from a low of -121.18% in Q1 2023 to a high of 73.46% in Q2 2025 over five years.
- On a year-over-year basis, FCF Margin increased in four of the last eight quarters, with an average year-over-year change of +3.70 percentage points.
- The strongest year-over-year quarter for FCF Margin in the past five years was Q3 2023, with a gain of 123.15 percentage points; the weakest was Q1 2023, with a drop of 98.38 percentage points.
- According to Business Quant data, FCF Margin for the three prior quarters was -23.19% (Q1 2026), 49.63% (Q4 2025) and -2.47% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,157.21 Bn | 1,125.80 Bn | 19.71 Bn | 33.76% |
| 2 | Johnson & Johnson | 624.79 Bn | 543.32 Bn | 17.26 Bn | 28.82% |
| 3 | AbbVie | 511.04 Bn | 484.15 Bn | 12.70 Bn | 18.33% |
| 4 | Merck | 365.98 Bn | 320.36 Bn | 12.21 Bn | 26.96% |
| 5 | Novartis Ag | 296.82 Bn | 260.81 Bn | 11.24 Bn | 38.60% |
| 6 | Astrazeneca | 260.38 Bn | 234.06 Bn | 12.86 Bn | 6.55% |
| 7 | Amgen | 234.75 Bn | 190.15 Bn | 7.24 Bn | 34.70% |
| 8 | Gilead Sciences | 193.87 Bn | 168.07 Bn | 6.22 Bn | 44.00% |
| 9 | Pfizer | 171.45 Bn | 118.10 Bn | 10.94 Bn | 2.01% |
| 10 | Emergent BioSolutions | 317.34 Mn | -433.56 Mn | 137.20 Mn | 23.05% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 23.05% |
| Mar 31, 2026 | -23.19% |
| Dec 31, 2025 | 49.63% |
| Sep 30, 2025 | -2.47% |
| Jun 30, 2025 | 73.46% |
| Mar 31, 2025 | -6.66% |
| Dec 31, 2024 | -41.91% |
| Sep 30, 2024 | 50.34% |
| Jun 30, 2024 | 16.84% |
| Mar 31, 2024 | -24.43% |
| Dec 31, 2023 | 7.48% |
| Sep 30, 2023 | 17.52% |
| Jun 30, 2023 | -37.56% |
| Mar 31, 2023 | -121.18% |
| Dec 31, 2022 | 20.96% |
| Sep 30, 2022 | -144.06% |
| Jun 30, 2022 | -19.66% |
| Mar 31, 2022 | -22.80% |
| Dec 31, 2021 | 38.52% |
| Sep 30, 2021 | -13.45% |
Emergent BioSolutions FCF Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=fcf-margin&ticker=EBS&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "fcf-margin", "ticker": "EBS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=fcf-margin&ticker=EBS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();